Cargando…
ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion
Glioblastoma (GBM) is the most aggressive primary intracranial tumor in adults. Chemoradiotherapy resistance and recurrence after surgery are the main malignant progression factors, leading to a high mortality rate. Therefore, the exploration of novel biomarkers and molecular mechanisms of GBM is ur...
Autores principales: | Yang, Li, Han, Na, Zhang, Xiaoxi, Zhou, Yangmei, Chen, Rui, Zhang, Mengxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160549/ https://www.ncbi.nlm.nih.gov/pubmed/32323832 http://dx.doi.org/10.3892/or.2020.7573 |
Ejemplares similares
-
NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma
por: Guo, Qiuyun, et al.
Publicado: (2019) -
Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
por: Zhou, Yangmei, et al.
Publicado: (2019) -
ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
Zwint facilitates melanoma progression by promoting c-Myc expression
por: Mou, Kuanhou, et al.
Publicado: (2021) -
Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic Cancer Cells
por: Kim, Jae Hyeong, et al.
Publicado: (2020)